Numis Securities Ltd reissued their buy rating on shares of BTG plc (LON:BTG) in a research report report published on Thursday, June 29th. The brokerage currently has a GBX 900 ($11.72) price objective on the stock.
A number of other research firms have also recently commented on BTG. J P Morgan Chase & Co reiterated a neutral rating and set a GBX 790 ($10.29) price objective on shares of BTG plc in a research report on Tuesday, March 28th. Panmure Gordon reiterated a buy rating and set a GBX 737 ($9.60) price objective on shares of BTG plc in a research report on Thursday, April 20th. Investec reiterated a buy rating and set a GBX 720 ($9.38) price objective on shares of BTG plc in a research report on Thursday, April 6th. Stifel Nicolaus reiterated a buy rating and set a GBX 725 ($9.45) price objective on shares of BTG plc in a research report on Tuesday, April 4th. Finally, Jefferies Group LLC reiterated a buy rating and set a GBX 775 ($10.10) price objective on shares of BTG plc in a research report on Tuesday, May 16th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of GBX 766.44 ($9.98).
Shares of BTG plc (LON BTG) traded down 0.84% during mid-day trading on Thursday, reaching GBX 652.50. 366,122 shares of the company’s stock were exchanged. BTG plc has a one year low of GBX 528.36 and a one year high of GBX 738.50. The company’s 50-day moving average price is GBX 677.82 and its 200-day moving average price is GBX 626.56. The company’s market capitalization is GBX 2.51 billion.
TRADEMARK VIOLATION WARNING: “BTG plc (LON:BTG) Receives Buy Rating from Numis Securities Ltd” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.chaffeybreeze.com/2017/07/29/btg-plcs-lonbtg-buy-rating-reiterated-at-numis-securities-ltd-updated-updated-updated.html.
In other BTG plc news, insider Rolf Soderstrom sold 22,624 shares of BTG plc stock in a transaction dated Friday, June 9th. The stock was sold at an average price of GBX 649 ($8.45), for a total value of £146,829.76 ($191,284.21).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.